Retinol saturase promotes adipogenesis and is downregulated in obesity.

TitleRetinol saturase promotes adipogenesis and is downregulated in obesity.
Publication TypeJournal Article
Year of Publication2009
AuthorsSchupp M, Lefterova MI, Janke J, Leitner K, Cristancho AG, Mullican SE, Qatanani M, Szwergold N, Steger DJ, Curtin JC, Kim RJ, Suh M-J, Suh M, Albert MR, Engeli S, Gudas LJ, Lazar MA
JournalProc Natl Acad Sci U S A
Volume106
Issue4
Pagination1105-10
Date Published2009 Jan 27
ISSN1091-6490
Keywords3T3-L1 Cells, Adipocytes, Adipogenesis, Animals, Base Sequence, Binding Sites, CCAAT-Enhancer-Binding Protein-beta, Down-Regulation, Enzyme Activation, Enzyme Induction, Female, Humans, Introns, Mice, Molecular Sequence Data, Nucleotides, Obesity, Oxidoreductases Acting on CH-CH Group Donors, PPAR gamma, Response Elements, Transcription, Genetic, Vitamin A
Abstract

Adipocyte differentiation is controlled by many transcription factors, but few known downstream targets of these factors are necessary for adipogenesis. Here we report that retinol saturase (RetSat), which is an enzyme implicated in the generation of dihydroretinoid metabolites, is induced during adipogenesis and is directly regulated by the transcription factor peroxisome proliferator activated receptor gamma (PPARgamma). Ablation of RetSat dramatically inhibited adipogenesis but, surprisingly, this block was not overcome by the putative product of RetSat enzymatic activity. On the other hand, ectopic RetSat with an intact, but not a mutated, FAD/NAD dinucleotide-binding motif increased endogenous PPARgamma transcriptional activity and promoted adipogenesis. Indeed, RetSat was not required for adipogenesis when cells were provided with exogenous PPARgamma ligands. In adipose tissue, RetSat is expressed in adipocytes but is unexpectedly downregulated in obesity, most likely owing to infiltration of macrophages that we demonstrate to repress RetSat expression. Thiazolidinedione treatment reversed low RetSat expression in adipose tissue of obese mice. Thus, RetSat plays an important role in the biology of adipocytes, where it favors normal differentiation, yet is reduced in the obese state. RetSat is thus a novel target for therapeutic intervention in metabolic disease.

DOI10.1073/pnas.0812065106
Alternate JournalProc. Natl. Acad. Sci. U.S.A.
PubMed ID19139408
PubMed Central IDPMC2633572
Grant ListF32 DK070405 / DK / NIDDK NIH HHS / United States
R01 DK049780 / DK / NIDDK NIH HHS / United States
R01 CA043796 / CA / NCI NIH HHS / United States
5-F32-DK-070405 / DK / NIDDK NIH HHS / United States
T32-DK07314 / DK / NIDDK NIH HHS / United States
R01 DK49780 / DK / NIDDK NIH HHS / United States
T32 DK007314 / DK / NIDDK NIH HHS / United States
R01 CA43796 / CA / NCI NIH HHS / United States